Anthem’s revenues totaled $29.3 billion in the second quarter of this year, up 14.9 percent year over year. Anthem attributed revenue growth in part to the launch of its pharmacy unit, IngenioRx, and higher premium revenue from increased growth in its Medicare and Medicaid lines.
The insurer’s expenses grew 8.8 percent year over year to $26.1 billion. Still, Anthem ended the quarter with a $2.3 billion profit, more than double the $1.1 billion the insurer posted in the same period a year prior. Reduced healthcare benefit use during the COVID-19 pandemic is part of the reason that Anthem said its profit grew.
Anthem said it has provided $2.5 billion in financial assistance to ease the burden of the COVID-19 pandemic for providers and members.
More articles on payers:
Anthem agrees to pay $27K medical bill after TV report airs
Leapfrog Group: Employers rank Cigna highest, UnitedHealthcare lowest on drive for value
Clover Health to triple footprint, expand coverage to 8 states
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
